Randomized trial explores end-of-life care decisions in very old ICU patients, highlighting prognosis and treatment options.
Key Points
This research aims to understand the complexities of end-of-life decisions for very old critically ill patients in the ICU.
Analysis of large international cohorts (VIP, VIP2, COVIP) focusing on treatment decisions
Assessment of factors influencing end-of-life care, such as frailty and functional status
Evaluation of shared decision-making processes involving healthcare providers and surrogate decision-makers.
Frailty is strongly associated with increased mortality and treatment limitations in very old patients (e.g., 30% of frail patients experienced treatment limitation)
Significant regional variation exists in end-of-life practices across international cohorts
Shared decision-making often fails, leading to discrepancies between patient preferences and actual care.